glp 1 receptor brain GLP-1 in the Hypothalamic Paraventricular Nucleus Promotes Sympathetic Activation and Hypertension GLP-1s are reinforcing a principle

These discrepancies may be explained by the hypothesis that L-carnitine supplementation accompanied by high amounts of carbohydrate intake increases skeletal muscle OCTN2 expression through an insulin-mediated mechanism, thereby increasing skeletal muscle carnitine content [28, 29]

GLP-1s now sound the death knell of the volume growth model for mainstream alcohol: brands banking on session drinking are heading into a headwind that marketing alone cannot fix. Its not, however, game over for alcohol

Most GLP-1R agonists have gastrointestinal side effects, including nausea, vomiting, diarrhea and constipation, which may be more pronounced in elderly patients with AD and affect treatment compliance

The Bottom Line Interest in next-generation weight-loss drugs like retatrutide will likely continue to grow

Less common but serious concerns - Acute pancreatitis has been reported with GLP-1 RAs

Novel GLP-1RAs improve efficacy and show promise beyond obesity such as addiction